What is the recommended treatment regimen for Brucella infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Brucellosis Management

Recommended First-Line Treatment

For uncomplicated brucellosis, doxycycline 100 mg twice daily orally for 6 weeks combined with streptomycin 15 mg/kg daily intramuscularly for 2-3 weeks is the preferred regimen, offering the lowest relapse rates. 1, 2

Treatment Algorithm for Uncomplicated Brucellosis

Primary Regimen (Lowest Relapse Rate)

  • Doxycycline 100 mg PO twice daily for 6 weeks PLUS Streptomycin 15 mg/kg IM daily for 2-3 weeks 1, 2
  • This combination demonstrates superior efficacy with relapse rates of only 5.3% compared to 16% with doxycycline-rifampicin 3
  • Meta-analysis confirms this regimen is significantly more effective than alternatives (OR = 3.17 favoring streptomycin over rifampicin) 4

Alternative First-Line Regimens (When Streptomycin Unavailable)

  • Doxycycline 100 mg PO twice daily for 6 weeks PLUS Gentamicin 5 mg/kg IV/IM daily as single dose for 7 days 1
  • WHO recommends this as first-line with comparable efficacy to streptomycin, offering the advantage of wider availability and shorter parenteral therapy duration 1
  • Note: Use weight-based dosing (5 mg/kg), NOT fixed 500 mg dosing 1
  • Failure/relapse rates are approximately 10-20%, which is about 5% higher than streptomycin-containing regimens 1

Second-Choice Oral Regimen

  • Doxycycline 100 mg PO twice daily for 6 weeks PLUS Rifampicin 600-900 mg PO daily (single morning dose) for 6 weeks 1, 2
  • This all-oral regimen has higher relapse rates (16% vs 5.3%) and combined failure rates of 24% vs 7.45% compared to doxycycline-streptomycin 3
  • Important caveat: In regions where tuberculosis coexists with brucellosis, avoid rifampicin due to risk of promoting mycobacterial resistance 1, 2

Cost-Effective Alternative (Resource-Limited Settings)

  • Trimethoprim-Sulfamethoxazole 800+160 mg PO twice daily for 6 weeks (combined with doxycycline or rifampicin) 1
  • CDC reports response rates above 90% when used appropriately 1
  • Systematic reviews show similar efficacy to doxycycline-rifampicin 5

Complicated Brucellosis

Brucellar Spondylitis (Spinal Involvement)

  • Aminoglycoside-containing regimens are superior to rifampicin-containing regimens 2, 6
  • Extend treatment duration beyond standard 6 weeks 2
  • Perform MRI when spinal involvement is suspected 6
  • If cervical spine involvement: immobilize spine immediately to prevent devastating neurological complications 6

Neurobrucellosis

  • Consider doxycycline + rifampicin + aminoglycoside (preferably gentamicin over streptomycin) if ceftriaxone cannot be used 6
  • MRI is mandatory when spinal involvement suspected 6

Brucellar Endocarditis

  • High mortality complication requiring aggressive management 2
  • Empirical antimicrobial selection with surgical intervention needed in most cases 2

Pediatric Considerations (Age <8 Years)

  • Trimethoprim-Sulfamethoxazole plus Rifampicin for 6 weeks is the regimen of choice 5
  • Alternative: Gentamicin for 5 days plus trimethoprim-sulfamethoxazole for 6 weeks 5
  • Avoid doxycycline due to dental staining risk in children under 8 years 5

Treatment Monitoring and Relapse Management

  • Standard treatment duration is 6 weeks for uncomplicated cases 1, 2
  • Relapse rates range from 5-15% even with appropriate treatment 1, 2
  • Relapses are usually mild and respond successfully to the same initial regimen 1, 2
  • Monotherapy shows significantly higher relapse rates (13% vs 4.8%) and should be avoided 5
  • Short-term treatment (<4 weeks) results in 22% relapse rate vs 4.8% with standard duration 5

Regimens to Avoid or Reserve

  • Quinolone-containing regimens (ofloxacin, ciprofloxacin) should be reserved as second or third agents only due to higher cost and antimicrobial resistance concerns 1
  • Triple therapy (aminoglycoside-doxycycline-rifampicin) cannot be considered first-line until better studied 4
  • Monotherapy with any agent is inadequate and leads to unacceptably high relapse rates 5

References

Guideline

Brucellosis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Brucellosis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Neurobrucellosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.